Your Cart is Empty
It's well-known that your daily coffee provides an energy boost, but new research reveals it may also deliver unexpected health benefits beyond just a morning pick-me-up. A new study reveals a surprising connection between coffee and liver health, with components like caffeine and antioxidants potentially offering protective benefits. Whether the coffee is decaf, instant, or ground, all seem to offer protection against chronic liver disease (CLD).
Consistent coffee drinkers showed a decreased likelihood of developing CLD, experiencing CLD steatosis, and dying from CLD. Peak benefits were noted with about 3-4 daily cups. Coffee is rich in antioxidants and bioactive elements that combat liver inflammation and oxidative damage, while specific compounds may enhance the body’s ability to detoxify harmful substances.
Caffeine may help reduce liver fibrosis by blocking specific receptors and pathways that trigger collagen production in the liver. Decaffeinated coffee also showed protective effects, suggesting other bioactive compounds, particularly abundant in ground coffee, play a role. Ground coffee, including espresso, demonstrated the strongest protective impact.
If you’re a coffee enthusiast concerned about liver health, this research offers another reason to savor your daily brew. However, moderation is key, as moderate coffee intake is linked to better liver health, while excessive consumption may harm your general health.
While these findings are promising, further research is required to fully clarify the mechanisms and establish precise recommendations for coffee consumption to support liver health.
To view the original scientific study click below:
All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study
If you notice a decline in your sense of smell, there may be reason for concern. Olfactory function naturally decreases with age, and its loss can also be an early indicator of neurodegenerative disorders. New research links a declining sense of smell to a faster accumulation of Alzheimer’s-related brain changes observed in brain scans.
Everywhere in our surroundings, minuscule plastic fragments invade the human body daily through foods and liquids we consume, and airborne particles we inhale. These pervasive invaders spread throughout every organ and tissue, reaching even the brain, where buildup may spark symptoms resembling Alzheimer's disease. A new study revealed concerning levels of microplastic buildup in the human brain.
Statins are currently being used by millions of Americans to reduce cholesterol and to prevent heart disease. A recent study reveals that statins may reduce circulating GLP-1 levels, potentially disrupting metabolism, increasing insulin resistance, and elevating blood sugar. This interference affects GLP-1, the hormone mimicked by weight-loss drugs like Ozempic, highlighting an overlooked metabolic impact.